Ischemic preconditioning-induced hyperperfusion correlates with hepatoprotection after liver resection

Table 3 Flow characteristics of patients undergoing PM (control, n = 30) and IP + PM (study group, n = 31)

Group	Vessel	Baseline (mL/min)	After IP (mL/min)	15 min (mL/min)	Before abd. closure (mL/min)
Control	HA	141 ± 24	-	152 ± 29	146 ± 18
IP	HA	126 ± 19	263 ± 51	196 ± 38a	174 ± 22a
Control	PV	1023 ± 130	-	726 ± 121	757 ± 58
IP	PV	930 ± 94	920 ± 81	919 ± 75a	949 ± 62a
Total (Co)	HA + PV	1164 ± 72	-	878 ± 77	903 ± 37c
Total (IP)	HA + PV	1056 ± 53	1183 ± 64	1115 ± 49b	1123 ± 58b

There were significantly enhanced PV, HA, and total flows in IP-treated patients. PM: Pringle maneuver; HA: Hepatic artery; PV: Portal vein; abd: Abdomen; Co: Control.

^aP < 0.05,

^bP < 0.01 vs control;

^cP < 0.05 vs baseline.